Contrarily, in differentiated cancer cells, FMD stimulates starvation escape pathways, including mTOR, PI3K/AKT, and CDK4/6, thus providing therapeutic targets that can lead to tumour regression with low toxicity [93]. The gene discussed is AKT1; the disease is neoplasm.